Oncologic outcomes of surgical para-aortic lymph node staging in patients with advanced cervical carcinoma undergoing chemoradiation

被引:11
作者
Nasioudis, Dimitrios [1 ]
Rush, Margaret [1 ]
Taunk, Neil K. [2 ]
Ko, Emily M. [1 ]
Haggerty, Ashley F. [1 ]
Cory, Lori [1 ]
Giuntoli, Robert L., II [1 ]
Kim, Sarah H. [1 ]
Latif, Nawar A. [1 ]
机构
[1] Penn Med, Div Gynecol Oncol, Philadelphia, PA USA
[2] Univ Penn, Perelman Sch Med, Radiat Oncol, Philadelphia, PA 19104 USA
关键词
Cervical Cancer; Lymph Nodes; Radiation; Lymphatic Metastasis; CANCER;
D O I
10.1136/ijgc-2022-003394
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives We aimed to evaluate the utilization and impact of surgical para-aortic lymph node staging on the survival of patients with locally advanced stage cervical carcinoma receiving definitive chemoradiation. Methods We identified patients in the National Cancer Database diagnosed between January 2010 and December 2015 with locally advanced (FIGO 2009 stage IB2-IVA) cervical carcinoma who did not undergo hysterectomy, received primary chemoradiation and had at least 1 month of follow-up. Two groups of patients were formed based on the assessment method of para-aortic lymph node status - radiologic assessment only versus surgical lymphadenectomy. Overall survival was compared with the log-rank test after Kaplan-Meier curves were generated. A Cox model was constructed to control for a priori selected confounders. Results We identified a total of 3540 patients who met the inclusion criteria. Para-aortic staging was performed in 333 (9.4%) patients. These patients were younger (median age 46 vs 52 years, p<0.001), less likely to have co-morbidities (8.7% vs 15.6%, p<0.001), more likely to have private insurance (48.9% vs 37.8%, p<0.001) and receive brachytherapy (76.9% vs 70.9%, p=0.022). The rate of para-aortic lymphadenectomy was comparable between patients with stage IB2-II and III-IVA disease (9.4% for both groups, p=0.98). Patients who underwent para-aortic lymphadenectomy were also more likely to have lymph nodes categorized as positive compared with those who had imaging only (27.3% vs 13.2%, p<0.001). There was no difference in overall survival between patients who underwent radiologic only or surgical para-aortic lymph node assessment (p=0.80 from log-rank test); 4 year overall survival rates were 62.9% and 63%. After controlling for confounders, performance of para-aortic lymphadenectomy was not associated with a survival benefit (HR 1.07, 95% CIs: 0.88 to 1.31). Conclusions In a large cohort of patients with locally advanced stage cervical carcinoma, para-aortic lymphadenectomy was rarely performed and not associated with a survival benefit.
引用
收藏
页码:823 / 827
页数:5
相关论文
共 17 条
  • [1] Cervical Cancer, Version 1.2020 Featured Updates to the NCCN Guidelines
    Abu-Rustum, Nadeem R.
    Yashar, Catheryn M.
    Bean, Sarah
    Bradley, Kristin
    Campos, Susana M.
    Chon, Hye Sook
    Chu, Christina
    Cohn, David
    Crispens, Marta Ann
    Damast, Shari
    Fisher, Christine M.
    Frederick, Peter
    Gaffney, David K.
    Giuntoli, Robert, II
    Han, Ernest
    Huh, Warner K.
    Lurain, John R., III
    Mariani, Andrea
    Mutch, David
    Nagel, Christa
    Nekhlyudov, Larissa
    Fader, Amanda Nickles
    Remmenga, Steven W.
    Reynolds, R. Kevin
    Sisodia, Rachel
    Tillmanns, Todd
    Ueda, Stefanie
    Urban, Renata
    Wyse, Emily
    McMillian, Nicole R.
    Motter, Angela D.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (06): : 661 - 666
  • [2] [18F]FDG-PET or PET/CT in the evaluation of pelvic and para-aortic lymph nodes in patients with locally advanced cervical cancer: A systematic review of the literature
    Adam, Judit A.
    van Diepen, Pascal R.
    Mom, Constantijne H.
    Stoker, Jaap
    van Eck-Smit, Berthe L. F.
    Bipat, Shandra
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 159 (02) : 588 - 596
  • [3] Cervical Cancer Trends in the United States: A 35-Year Population-Based Analysis
    Adegoke, Olusola
    Kulasingam, Shalini
    Virnig, Beth
    [J]. JOURNAL OF WOMENS HEALTH, 2012, 21 (10) : 1031 - 1037
  • [4] Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer
    Brockbank, Elly
    Kokka, Fani
    Bryant, Andrew
    Pomel, Christophe
    Reynolds, Karina
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (03):
  • [5] Therapeutic value of surgical paraaortic staging in locally advanced cervical cancer: a multicenter cohort analysis from the FRANCOGYN study group
    Dabi, Yohann
    Simon, Vanille
    Carcopino, Xavier
    Bendifallah, Sofiane
    Ouldamer, Lobna
    Lavoue, Vincent
    Canlorbe, Geoffroy
    Raimond, Emilie
    Coutant, Charles
    Graesslin, Olivier
    Collinet, Pierre
    Bricou, Alexandre
    Darai, Emile
    Huchon, Cyrille
    Ballester, Marcos
    Haddad, Bassam
    Touboul, Cyril
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [6] Surgical or imaging lymph node assessment in locally advanced cervical cancer: a systematic review and meta-analysis
    Delara, Ritchie
    Yang, Jie
    Buckner-Petty, Skye
    Magtibay, Paul
    Butler, Kristina
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (06) : 1 - 11
  • [7] Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma - A Gynecologic oncology group study
    Gold, Michael A.
    Tian, Chunqiao
    Whitney, Charles W.
    Rose, Peter G.
    Lanciano, Rachelle
    [J]. CANCER, 2008, 112 (09) : 1954 - 1963
  • [8] Lack of Survival Benefit of Para-Aortic Lymphadenectomy in Advanced Cervical Cancer
    Gonzalez-Benitez, Cristina
    Salas, Patricia
    Grabowski, Jacek P.
    Hernandez, Alicia
    De Santiago, Javier
    Zapardiel, Ignacio
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2019, 84 (04) : 407 - 411
  • [9] Nodal-staging surgery for locally advanced cervical cancer in the era of PET
    Gouy, Sebastien
    Morice, Philippe
    Narducci, Fabrice
    Uzan, Catherine
    Gilmore, Jennifer
    Kolesnikov-Gauthier, Helene
    Querleu, Denis
    Haie-Meder, Christine
    Leblanc, Eric
    [J]. LANCET ONCOLOGY, 2012, 13 (05) : E212 - E220
  • [10] Huang Marilyn, 2009, Rev Obstet Gynecol, V2, P101